These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 23770117)

  • 1. Novel colloidal carriers for psoriasis: current issues, mechanistic insight and novel delivery approaches.
    Pradhan M; Singh D; Singh MR
    J Control Release; 2013 Sep; 170(3):380-95. PubMed ID: 23770117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Topical Nanocarriers for Treatment of Psoriasis: An Overview.
    Dadwal A; Mishra N; Narang RK
    Curr Pharm Des; 2018; 24(33):3934-3950. PubMed ID: 30387390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammatory Bowel Disease: Pathogenesis, Causative Factors, Issues, Drug Treatment Strategies, and Delivery Approaches.
    Singh D; Srivastava S; Pradhan M; Kanwar JR; Singh MR
    Crit Rev Ther Drug Carrier Syst; 2015; 32(3):181-214. PubMed ID: 26080808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanocarriers Mediated Topical Drug Delivery for Psoriasis Treatment.
    Gungor S; Rezigue M
    Curr Drug Metab; 2017; 18(5):454-468. PubMed ID: 28228078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising Strategies of Colloidal Drug Delivery-Based Approaches in Psoriasis Management.
    Singh S; Sharma N; Behl T; Sarkar BC; Saha HR; Garg K; Singh SK; Arora S; Amran MS; Abdellatif AAH; Bilgrami AL; Ashraf GM; Rahman MS
    Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel drug delivery systems in topical treatment of psoriasis: rigors and vigors.
    Katare OP; Raza K; Singh B; Dogra S
    Indian J Dermatol Venereol Leprol; 2010; 76(6):612-21. PubMed ID: 21079304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-lipoidal carriers of tretinoin with enhanced percutaneous absorption, photostability, biocompatibility and anti-psoriatic activity.
    Raza K; Singh B; Lohan S; Sharma G; Negi P; Yachha Y; Katare OP
    Int J Pharm; 2013 Nov; 456(1):65-72. PubMed ID: 23973754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exploring the potential of nanocarriers in antipsoriatic therapeutics.
    Shaif M; Kushwaha P; Usmani S; Pandey S
    J Dermatolog Treat; 2022 Nov; 33(7):2919-2930. PubMed ID: 35729857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanostructured lipid carriers system: recent advances in drug delivery.
    Iqbal MA; Md S; Sahni JK; Baboota S; Dang S; Ali J
    J Drug Target; 2012 Dec; 20(10):813-30. PubMed ID: 22931500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the prospective of nano-formulations towards the treatment of psoriasis.
    Pradhan M; Alexander A; Singh MR; Singh D; Saraf S; Saraf S; Ajazuddin
    Biomed Pharmacother; 2018 Nov; 107():447-463. PubMed ID: 30103117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nail Psoriasis Treatment: Insights into Current Progress and Future Trends.
    Nirbhavane P; Sharma G; Verma S; Jadon RS; Singh B; Katare OP
    Crit Rev Ther Drug Carrier Syst; 2020; 37(2):135-159. PubMed ID: 32865903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential enhancement and targeting strategies of polymeric and lipid-based nanocarriers in dermal drug delivery.
    Kahraman E; Güngör S; Özsoy Y
    Ther Deliv; 2017 Nov; 8(11):967-985. PubMed ID: 29061106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plants and plant products with potential antipsoriatic activity--a review.
    Kaur A; Kumar S
    Pharm Biol; 2012 Dec; 50(12):1573-91. PubMed ID: 22971237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in psoriasis physiopathology and treatments: Up to date of mechanistic insights and perspectives of novel therapies based on innovative skin drug delivery systems (ISDDS).
    Sala M; Elaissari A; Fessi H
    J Control Release; 2016 Oct; 239():182-202. PubMed ID: 27381248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An overview of topical lipid-based and polymer-based nanocarriers for treatment of psoriasis.
    Aziz Hazari S; Kaur H; Karwasra R; Abourehab MAS; Ali Khan A; Kesharwani P
    Int J Pharm; 2023 May; 638():122938. PubMed ID: 37031809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine-based drug targeting for psoriasis: potentials and emerging trends in nanoscale pharmacotherapy.
    Rahman M; Akhter S; Ahmad J; Ahmad MZ; Beg S; Ahmad FJ
    Expert Opin Drug Deliv; 2015 Apr; 12(4):635-52. PubMed ID: 25439967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Standardized in vitro drug release test for colloidal drug carriers using modified USP dissolution apparatus I.
    Abdel-Mottaleb MM; Lamprecht A
    Drug Dev Ind Pharm; 2011 Feb; 37(2):178-84. PubMed ID: 21073322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assembling nanoparticle coatings to improve the drug delivery performance of lipid based colloids.
    Simovic S; Barnes TJ; Tan A; Prestidge CA
    Nanoscale; 2012 Feb; 4(4):1220-30. PubMed ID: 22159191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanotechnological carriers for cancer chemotherapy: the state of the art.
    Estanqueiro M; Amaral MH; Conceição J; Sousa Lobo JM
    Colloids Surf B Biointerfaces; 2015 Feb; 126():631-48. PubMed ID: 25591851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study.
    González-Paredes A; Manconi M; Caddeo C; Ramos-Cormenzana A; Monteoliva-Sánchez M; Fadda AM
    J Liposome Res; 2010 Dec; 20(4):269-76. PubMed ID: 19954402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.